Literature DB >> 21544085

Assessment of arterial stiffness from ambulatory blood pressure monitoring in children with diabetes mellitus type-1 (DMT1).

T Suláková1, J Janda, J Cerná, V Janštová, J Feber.   

Abstract

Pulse pressure (PP) and ambulatory arterial stiffness index (AASI) can be calculated from ambulatory blood pressure (BP) monitoring (ABPM) and have been suggested as markers of arterial stiffness and predictors of cardiovascular mortality. We retrospectively evaluated PP and AASI from ABPM records in 84 children (43 boys) with diabetes mellitus type-1 (DMT1) compared with 27 non-diabetic normotensive children. Based on office BP and ABPM, patients with DMT1 were divided into three groups: 24/84 (29%) had hypertension (DM HTN), 33/84 (39%) were normotensive (DM NT) and 27/84 (32%) had white-coat hypertension (DM WCH). DM WCH and DM HTN patients had significantly higher PP when compared with DM NT and NT patients alone (47.62 ± 7.31 and 47.43 ± 8.68 versus 41.45 ± 4.44 and 42.18 ± 5.97, respectively, P=0.0002). Similarly, AASI was significantly elevated in both DM WCH and DM HTN patients when compared with NT patients (0.35 ± 0.14 and 0.36 ± 0.15 versus 0.23 ± 0.15, respectively, P=0.007). In conclusion, children with DMT1 and hypertension, including WCH, had significantly higher PP and AASI levels when compared with normotensive patients. This suggests that these children may be at an increased risk for developing cardiovascular complications later on in life.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544085     DOI: 10.1038/jhh.2011.38

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  8 in total

Review 1.  Abnormalities of vascular structure and function in pediatric hypertension.

Authors:  Elaine M Urbina
Journal:  Pediatr Nephrol       Date:  2015-08-15       Impact factor: 3.714

2.  Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association.

Authors:  Joseph T Flynn; Stephen R Daniels; Laura L Hayman; David M Maahs; Brian W McCrindle; Mark Mitsnefes; Justin P Zachariah; Elaine M Urbina
Journal:  Hypertension       Date:  2014-03-03       Impact factor: 10.190

3.  Nighttime blood pressure, systolic blood pressure variability, and left ventricular mass index in children with hypertension.

Authors:  Ajay P Sharma; Javed Mohammed; Benson Thomas; Nathan Lansdell; Kambiz Norozi; Guido Filler
Journal:  Pediatr Nephrol       Date:  2013-04-07       Impact factor: 3.714

4.  Technological Ecological Momentary Assessment Tools to Study Type 1 Diabetes in Youth: Viewpoint of Methodologies.

Authors:  Mary Katherine Ray; Alana McMichael; Maria Rivera-Santana; Jacob Noel; Tamara Hershey
Journal:  JMIR Diabetes       Date:  2021-06-03

5.  The Prevalence of Pre-hypertension in Children with Type 1 Diabetes Mellitus.

Authors:  Farzaneh Rohani; Nakysa Hooman; Sedighe Moradi; Mehdi Mobarra; Mehri Najafizadeh; Parvin Tatarpoor
Journal:  Int J Prev Med       Date:  2014-03

6.  Elevated glycated hemoglobin levels impair blood pressure in children and adolescents with type 1 diabetes mellitus.

Authors:  Sandra de Oliveira; Dahan da Cunha Nascimento; Ramires Alsamir Tibana; Samuel Lima de Oliveira; Ivo Vieira de Sousa Neto; Roberta Kelly Menezes Maciel Falleiros; Leonardo Garcia Miranda; Hermelinda Cordeiro Pedrosa; James Wilfred Navalta; Guilherme Borges Pereira; Jonato Prestes
Journal:  Diabetol Metab Syndr       Date:  2016-01-12       Impact factor: 3.320

7.  Cardiac and Vascular Target Organ Damage in Pediatric Hypertension.

Authors:  Michael Khoury; Elaine M Urbina
Journal:  Front Pediatr       Date:  2018-05-24       Impact factor: 3.418

8.  Blood pressure during sleep is associated with arterial stiffness and urine microalbumin to creatinine ratio in youth with type 1 diabetes.

Authors:  Evgenia Gourgari; Mihriye Mete; Margarita Dimatulac; Fran Cogen; Tammy Brady
Journal:  J Diabetes Complications       Date:  2020-07-18       Impact factor: 2.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.